Document is current

Article History

Received: 9 August 2023

Accepted: 8 October 2023

First Online: 30 October 2023

Declarations

:

: Fang Ba receives research funding from the Social Sciences and Humanities Research Council of Canada (SSHRC), Brain Canada and The Neurosciences Rehabilitation, and Vision Strategic Clinical Network™ Research Grant. Funding in the last 12 months includes funding from Social Sciences and Humanities Research Council of Canada (SSHRC), and Brain Canada. Simon Duchesne receives peer reviewed funding from the Canadian Institutes for Health Research, the Canadian Space Agency; the Natural Science and Engineering Research Council, and is the co-founder and shareholder of True Positive Medical Devices Inc. Mario Masellis receives operating grants from the Canadian Institutes of Health Research, Ontario Brain Institute, Weston Brain Institute, Washington University—paid to institution, does contract clinical trial research for Alector Pharmaceuticals—paid to institution, receives royalties from Henry Stewart Talks, and receives consulting fees from Alector Pharmaceuticals, Wave Life Sciences, and Biogen Canada. Sandra E. Black receives contract research funding from GE Healthcare, Genentech, Optina, Roche, Eli Lilly, Eisa/Biogen Idec, NovoNordisk, Lilly Avid for which no personal fees were taken and payments were made to the institution, and also receives peer reviewed funding from: Ontario Brain Institute, CIHR, Leducq Foundation, Heart and Stroke Foundation of Canada, NIH, Alzheimer's Drug Discovery Foundation, Brain Canada, Weston Brain Institute, Canadian Partnership for Stroke Recovery, Canadian Foundation for Innovation, Focused Ultrasound Foundation, Alzheimer's Association US, Department of National Defence, Montreal Medical International Kuwait, Queen’s University, Compute Canada Resources for Research Groups, CANARIE, Networks of Centres of Excellence of Canada for which no personal fees were taken and payments were made to the institution. Funding in the last 12 months includes funding from Biogen, Roche and NovoNordisk for CME and ad hoc consulting (personal). Eric E Smith reports personal consulting fees from Alnylam and Eli Lilly, unrelated to the present work. Manuel Montero-Odasso receives research funding from the Canadian Institutes for Health Research (CIHR) and Weston Family Foundation and declare no conflicts of interest related to the current project. Funding in the last 12 months includes funding for Team 12 (Mobility, Exercise and Cognition) from CIHR via the Canadian Consortium on Neurodegeneration (CCNA) and the Comprehensive Assess of Neurodegeneration and Dementia Study (Compass-ND), Ontario Brain Institute, and Weston Family Foundation. Richard Camicioli receives research funding from the Canadian Institutes for Health Research (CIHR), Brain Canada and the National Institutes of Health (NIH) and declare no conflicts of interest related to the current project. Funding in the last 12 months includes funding for Team 8 (Lewy Body Disease) from CIHR via the Canadian Consortium on Neurodegeneration (CCNA) and the Comprehensive Assess of Neurodegeneration and Dementia Study (Compass-ND) and from CIHR and Brain Canada for the Functional Assessment of Vascular Reactivity in Small Vessel Disease (FAVR-2) study via a subcontract from the University of Calgary and from the NIH as a site for the SPARX3 study.

: The study protocol was carried out in accordance with The Code of Ethics of the World Medical Association. Participants provided written informed consent to prior to participating.

: The authors report no disclosures related to the current study.